M. Lynn Crismon, Pharm.D., FCCP, DABCP, BCPP

Dr. Crismon is Dean Emeritus and Behrens Centennial Professor Emeritus in the College of Pharmacy and Professor in the Department of Psychiatry and Behavioral Sciences, Dell Medical School, at The University of Texas at Austin. He has served his entire academic career at UT, and from 2007 to 2020 he served as Dean and James T. Doluisio Regents Chair of the UT College of Pharmacy. Dr. Crismon received his BS degree in Pharmacy from The University of Oklahoma and his Doctor of Pharmacy from a joint degree program of The University of Texas at Austin and The University of Texas Health Science Center at San Antonio. He completed residencies in pharmacy practice at the USPHS Gallup Indian Medical Center and in psychiatric pharmacy at The University of Texas and San Antonio State Hospital, and completed a National Endowment for the Humanities–funded summer fellowship in biomedical ethics, with a focus on cross-cultural ethics, at the Kennedy Institute for Ethics, Georgetown University. He served as a visiting professor for the Institute of Mental Health, National Health Group, Singapore, and for the pharmacy program at the University of Technology, Kingston, Jamaica. He is board certified in psychiatric pharmacy by the Board of Pharmacy Specialties, and he is a Diplomate of the American Board of Clinical Pharmacology.

His research, scholarship, and practice have focused on the development and evaluation of strategies to improve the pharmacotherapy and health outcomes of adults and children with severe mental disorders. Dr. Crismon served as Co-Director of the Texas Medication Algorithm Project and as Director of the Children’s Medication Algorithm Project. During his career, he received research grants from federal agencies, the State of Texas, nonprofit foundations, and the pharmaceutical industry. From 2004 through 2023, he co-chaired the development and revisions of the Psychotropic Medication Utilization Parameters for Children and Youth in Foster Care for the Texas Health and Human Services Commission. The 6^th edition was released in 2019 with a new title of Psychotropic Medication Utilization Parameters for Children and Youth in Texas Public Behavioral Health, thus applying the prescribing parameters to all Texas youth receiving mental health care through Texas Medicaid and CHIP. The 7^th edition of the medication tables was released in 2023. He is a founding member of the steering committee, faculty, and coach that developed the REACH Institute’s Patient-centered Mental Health in Pediatric Primary Care Program, and he currently serves as mental health vice chair of the steering committee. He served as a member of the National Academies of Science, Engineering, and Medicine Committee that developed the 2019 consensus report Taking Action Against Clinician Burnout: A Systems Approach to Professional Well-Being which received the 2021 James A. Hamilton Book Award from the American College of Healthcare Executives.

Prior to becoming dean in 2007, Dr. Crismon developed a nationally recognized training program in psychiatric pharmacotherapy and mental health outcomes research. He supervised 39 post Pharm.D. psychiatric pharmacy residents, research fellows, or graduate students. He served as supervisor for the ASHP Foundation Psychiatric Drug Therapy Research Fellowship (twice), the American College of Clinical Pharmacy (ACCP) Psychopharmacy Research Fellowship, the U.S. Pharmacopoeia Fellowship, and the NIMH F 32 post professional doctorate research-training award. Seven of his research trainees were awarded New Investigator Awards by the NIMH at the New Clinical Drug Evaluation Unit Meeting (NCDEU). In addition to over 270 articles, chapters, books, or handbooks to his credit, he has over 210 abstracts in print and has delivered more than 470 invited lectures or presentations. He served as associate editor of the APhA Drug Treatment Protocols, 2^nd edition and as a member of the editorial boards for The Annals of Pharmacotherapy, the Journal of the American Pharmacists Association (JAPhA), the APhA DrugInfoLine, the American Journal of Pharmaceutical Education, and Mental Health Clinician.

Dr. Crismon served as a member of the ACCP Board of Regents, the ACCP Research Institute Board of Trustees, and he is an ACCP fellow. He is a past chair of the American Association of Colleges of Pharmacy (AACP) Council of Deans, and past member of the AACP Board of Directors. He is a past member of the Board of Directors for the National Institute for Pharmaceutical Technology and Education (NIPTE). A past chair of the ASHP Specialty Practice Group on Psychopharmacy and chair of the task force to recognize psychiatric pharmacy as a specialty by the Board of Pharmacy Specialties (BPS), he was the first chair of the BPS Specialty Council on Psychiatric Pharmacy Practice that developed the first board certification exam for psychiatric pharmacy. He is a past president and past treasurer of the Texas Society of Health-System Pharmacists (TSHP) and the TSHP R&E Foundation. He currently serves as a member of the Texas Health Improvement Network (THIN) Advisory Council, a member of the Commission on Innovation and Advancement for the American Association of Psychiatric Pharmacists, ACCP Nominations Committee, and the Annual Meeting Program Committee for the American Society for Clinical Psychopharmacology. He is a faculty member and coach in the ASHP Clinician Well-being and Ambassadors Program that is funded by a HRSA grant.

Dr. Crismon is a recipient of the University of Oklahoma College of Pharmacy Distinguished Alumnus Award and the Philip C. and Ethyl F. Ashby Endowed Lecture Award, the UTCOP-TSHP Robert G. Leonard Memorial Lecture Award, the American Association of Psychiatric Pharmacists Judith K. Saklad Lecture Award, the Creighton University Rho Chi Lecture Award, the First Tennessee Chair of Excellence Distinguished Visiting Professor, College of Pharmacy, The University of Tennessee Health Sciences Center, and he was the 2010 Teacher of the Year for the UT Southwestern Medical Center – Austin Child and Adolescent Psychiatry Fellowship. In 2021, he was awarded the ACCP Paul F. Parker Medal and the ASHP Board of Directors Distinguished Leadership Award. He is the 2022 recipient of the West Texas Pharmacy Association’s Heritage Award, the 2022 UTCOP Legends of Pharmacy Award, and the 2024 AACP Paul R. Dawson Award for Excellence in Patient Care Research Award.